Selected research
Industry Research
Prothrombin Complex Concentrate(PCC) Industry Research Report 2026
Market perspective
The global Prothrombin Complex Concentrate(PCC) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Prothrombin Complex Concentrate(PCC) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Prothrombin Complex Concentrate(PCC) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Prothrombin Complex Concentrate(PCC) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Prothrombin Complex Concentrate(PCC) include CSL, WEIGUANG BIOLOGICAL, Taibang Biologic Group, SHANGHAI RAAS, Green Cross, Jiangxi Boya Bio-Pharmaceutical, HUALAN BIOLOGICAL ENGINEERING, Guangdong Shuanglin Biopharmaceutical and Beijing Tiantan Biological Products, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Prothrombin Complex Concentrate(PCC) market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Prothrombin Complex Concentrate(PCC) Market by Company
CSL
WEIGUANG BIOLOGICAL
Taibang Biologic Group
SHANGHAI RAAS
Green Cross
Jiangxi Boya Bio-Pharmaceutical
HUALAN BIOLOGICAL ENGINEERING
Guangdong Shuanglin Biopharmaceutical
Beijing Tiantan Biological Products
BOHUI
Biotest
Prothrombin Complex Concentrate(PCC) Segment by Type
1000IU
100IU
200IU
300IU
400IU
Prothrombin Complex Concentrate(PCC) Segment by Application
Hopistial
Clinic
Others
Prothrombin Complex Concentrate(PCC) Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prothrombin Complex Concentrate(PCC) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Prothrombin Complex Concentrate(PCC) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prothrombin Complex Concentrate(PCC).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Prothrombin Complex Concentrate(PCC) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Prothrombin Complex Concentrate(PCC) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Prothrombin Complex Concentrate(PCC) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 1000IU
- 100IU
- 200IU
- 300IU
- 400IU
Applications
- Hopistial
- Clinic
- Others
Companies covered
- CSL
- WEIGUANG BIOLOGICAL
- Taibang Biologic Group
- SHANGHAI RAAS
- Green Cross
- Jiangxi Boya Bio-Pharmaceutical
- HUALAN BIOLOGICAL ENGINEERING
- Guangdong Shuanglin Biopharmaceutical
- Beijing Tiantan Biological Products
- BOHUI
- Biotest
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Prothrombin Complex Concentrate(PCC) Market Size (2021-2032)
- 2.2.2 Global Prothrombin Complex Concentrate(PCC) Sales (2021-2032)
- 2.2.3 Global Prothrombin Complex Concentrate(PCC) Market Average Price (2021-2032)
- 2.3 Prothrombin Complex Concentrate(PCC) by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 1000IU
- 2.3.3 100IU
- 2.3.4 200IU
- 2.3.5 300IU
- 2.3.6 400IU
- 2.4 Prothrombin Complex Concentrate(PCC) by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hopistial
- 2.4.3 Clinic
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Prothrombin Complex Concentrate(PCC) Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Prothrombin Complex Concentrate(PCC) Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Prothrombin Complex Concentrate(PCC) Revenue of Manufacturers (2021-2026)
- 3.4 Global Prothrombin Complex Concentrate(PCC) Average Price by Manufacturers (2021-2026)
- 3.5 Global Prothrombin Complex Concentrate(PCC) Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Prothrombin Complex Concentrate(PCC), Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Prothrombin Complex Concentrate(PCC), Product Type & Application
- 3.8 Global Manufacturers of Prothrombin Complex Concentrate(PCC), Established Date
- 3.9 Global Prothrombin Complex Concentrate(PCC) Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 CSL
- 4.1.1 CSL Company Information
- 4.1.2 CSL Business Overview
- 4.1.3 CSL Prothrombin Complex Concentrate(PCC) Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 CSL Prothrombin Complex Concentrate(PCC) Product Portfolio
- 4.1.5 CSL Recent Developments
- 4.2 WEIGUANG BIOLOGICAL
- 4.2.1 WEIGUANG BIOLOGICAL Company Information
- 4.2.2 WEIGUANG BIOLOGICAL Business Overview
- 4.2.3 WEIGUANG BIOLOGICAL Prothrombin Complex Concentrate(PCC) Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 WEIGUANG BIOLOGICAL Prothrombin Complex Concentrate(PCC) Product Portfolio
- 4.2.5 WEIGUANG BIOLOGICAL Recent Developments
- 4.3 Taibang Biologic Group
- 4.3.1 Taibang Biologic Group Company Information
- 4.3.2 Taibang Biologic Group Business Overview
- 4.3.3 Taibang Biologic Group Prothrombin Complex Concentrate(PCC) Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Taibang Biologic Group Prothrombin Complex Concentrate(PCC) Product Portfolio
- 4.3.5 Taibang Biologic Group Recent Developments
- 4.4 SHANGHAI RAAS
- 4.4.1 SHANGHAI RAAS Company Information
- 4.4.2 SHANGHAI RAAS Business Overview
- 4.4.3 SHANGHAI RAAS Prothrombin Complex Concentrate(PCC) Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 SHANGHAI RAAS Prothrombin Complex Concentrate(PCC) Product Portfolio
- 4.4.5 SHANGHAI RAAS Recent Developments
- 4.5 Green Cross
- 4.5.1 Green Cross Company Information
- 4.5.2 Green Cross Business Overview
- 4.5.3 Green Cross Prothrombin Complex Concentrate(PCC) Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Green Cross Prothrombin Complex Concentrate(PCC) Product Portfolio
- 4.5.5 Green Cross Recent Developments
- 4.6 Jiangxi Boya Bio-Pharmaceutical
- 4.6.1 Jiangxi Boya Bio-Pharmaceutical Company Information
- 4.6.2 Jiangxi Boya Bio-Pharmaceutical Business Overview
- 4.6.3 Jiangxi Boya Bio-Pharmaceutical Prothrombin Complex Concentrate(PCC) Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Jiangxi Boya Bio-Pharmaceutical Prothrombin Complex Concentrate(PCC) Product Portfolio
- 4.6.5 Jiangxi Boya Bio-Pharmaceutical Recent Developments
- 4.7 HUALAN BIOLOGICAL ENGINEERING
- 4.7.1 HUALAN BIOLOGICAL ENGINEERING Company Information
- 4.7.2 HUALAN BIOLOGICAL ENGINEERING Business Overview
- 4.7.3 HUALAN BIOLOGICAL ENGINEERING Prothrombin Complex Concentrate(PCC) Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 HUALAN BIOLOGICAL ENGINEERING Prothrombin Complex Concentrate(PCC) Product Portfolio
- 4.7.5 HUALAN BIOLOGICAL ENGINEERING Recent Developments
- 4.8 Guangdong Shuanglin Biopharmaceutical
- 4.8.1 Guangdong Shuanglin Biopharmaceutical Company Information
- 4.8.2 Guangdong Shuanglin Biopharmaceutical Business Overview
- 4.8.3 Guangdong Shuanglin Biopharmaceutical Prothrombin Complex Concentrate(PCC) Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Guangdong Shuanglin Biopharmaceutical Prothrombin Complex Concentrate(PCC) Product Portfolio
- 4.8.5 Guangdong Shuanglin Biopharmaceutical Recent Developments
- 4.9 Beijing Tiantan Biological Products
- 4.9.1 Beijing Tiantan Biological Products Company Information
- 4.9.2 Beijing Tiantan Biological Products Business Overview
- 4.9.3 Beijing Tiantan Biological Products Prothrombin Complex Concentrate(PCC) Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Beijing Tiantan Biological Products Prothrombin Complex Concentrate(PCC) Product Portfolio
- 4.9.5 Beijing Tiantan Biological Products Recent Developments
- 4.10 BOHUI
- 4.10.1 BOHUI Company Information
- 4.10.2 BOHUI Business Overview
- 4.10.3 BOHUI Prothrombin Complex Concentrate(PCC) Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 BOHUI Prothrombin Complex Concentrate(PCC) Product Portfolio
- 4.10.5 BOHUI Recent Developments
- 4.11 Biotest
- 4.11.1 Biotest Company Information
- 4.11.2 Biotest Business Overview
- 4.11.3 Biotest Prothrombin Complex Concentrate(PCC) Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Biotest Prothrombin Complex Concentrate(PCC) Product Portfolio
- 4.11.5 Biotest Recent Developments
5 Global Prothrombin Complex Concentrate(PCC) Market Scenario by Region
- 5.1 Global Prothrombin Complex Concentrate(PCC) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Prothrombin Complex Concentrate(PCC) Sales by Region: 2021-2032
- 5.2.1 Global Prothrombin Complex Concentrate(PCC) Sales by Region: 2021-2026
- 5.2.2 Global Prothrombin Complex Concentrate(PCC) Sales by Region: 2027-2032
- 5.3 Global Prothrombin Complex Concentrate(PCC) Revenue by Region: 2021-2032
- 5.3.1 Global Prothrombin Complex Concentrate(PCC) Revenue by Region: 2021-2026
- 5.3.2 Global Prothrombin Complex Concentrate(PCC) Revenue by Region: 2027-2032
- 5.4 North America Prothrombin Complex Concentrate(PCC) Market Facts & Figures by Country
- 5.4.1 North America Prothrombin Complex Concentrate(PCC) Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Prothrombin Complex Concentrate(PCC) Sales by Country (2021-2032)
- 5.4.3 North America Prothrombin Complex Concentrate(PCC) Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Prothrombin Complex Concentrate(PCC) Market Facts & Figures by Country
- 5.5.1 Europe Prothrombin Complex Concentrate(PCC) Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Prothrombin Complex Concentrate(PCC) Sales by Country (2021-2032)
- 5.5.3 Europe Prothrombin Complex Concentrate(PCC) Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Prothrombin Complex Concentrate(PCC) Market Facts & Figures by Country
- 5.6.1 Asia Pacific Prothrombin Complex Concentrate(PCC) Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Prothrombin Complex Concentrate(PCC) Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Prothrombin Complex Concentrate(PCC) Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Prothrombin Complex Concentrate(PCC) Market Facts & Figures by Country
- 5.7.1 South America Prothrombin Complex Concentrate(PCC) Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Prothrombin Complex Concentrate(PCC) Sales by Country (2021-2032)
- 5.7.3 South America Prothrombin Complex Concentrate(PCC) Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Prothrombin Complex Concentrate(PCC) Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Prothrombin Complex Concentrate(PCC) Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Prothrombin Complex Concentrate(PCC) Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Prothrombin Complex Concentrate(PCC) Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Prothrombin Complex Concentrate(PCC) Sales by Type (2021-2032)
- 6.1.1 Global Prothrombin Complex Concentrate(PCC) Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Type (2021-2032)
- 6.2 Global Prothrombin Complex Concentrate(PCC) Revenue by Type (2021-2032)
- 6.2.1 Global Prothrombin Complex Concentrate(PCC) Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Prothrombin Complex Concentrate(PCC) Revenue Market Share by Type (2021-2032)
- 6.3 Global Prothrombin Complex Concentrate(PCC) Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Prothrombin Complex Concentrate(PCC) Sales by Application (2021-2032)
- 7.1.1 Global Prothrombin Complex Concentrate(PCC) Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Application (2021-2032)
- 7.2 Global Prothrombin Complex Concentrate(PCC) Revenue by Application (2021-2032)
- 7.2.1 Global Prothrombin Complex Concentrate(PCC) Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Prothrombin Complex Concentrate(PCC) Revenue Market Share by Application (2021-2032)
- 7.3 Global Prothrombin Complex Concentrate(PCC) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Prothrombin Complex Concentrate(PCC) Value Chain Analysis
- 8.1.1 Prothrombin Complex Concentrate(PCC) Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Prothrombin Complex Concentrate(PCC) Production Mode & Process
- 8.2 Prothrombin Complex Concentrate(PCC) Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Prothrombin Complex Concentrate(PCC) Distributors
- 8.2.3 Prothrombin Complex Concentrate(PCC) Customers
9 Global Prothrombin Complex Concentrate(PCC) Analyzing Market Dynamics
- 9.1 Prothrombin Complex Concentrate(PCC) Industry Trends
- 9.2 Prothrombin Complex Concentrate(PCC) Industry Drivers
- 9.3 Prothrombin Complex Concentrate(PCC) Industry Opportunities and Challenges
- 9.4 Prothrombin Complex Concentrate(PCC) Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst